Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

The HK2 Dependent "Warburg Effect" and Mitochondrial Oxidative Phosphorylation in Cancer: Targets for Effective Therapy with 3-Bromopyruvate.

Lis P, Dyląg M, Niedźwiecka K, Ko YH, Pedersen PL, Goffeau A, Ułaszewski S.

Molecules. 2016 Dec 15;21(12). pii: E1730. Review.

2.

Glutathione may have implications in the design of 3-bromopyruvate treatment protocols for both fungal and algal infections as well as multiple myeloma.

Niedźwiecka K, Dyląg M, Augustyniak D, Majkowska-Skrobek G, Cal-Bąkowska M, Ko YH, Pedersen PL, Goffeau A, Ułaszewski S.

Oncotarget. 2016 Oct 4;7(40):65614-65626. doi: 10.18632/oncotarget.11592.

3.

Screening the yeast genome for energetic metabolism pathways involved in a phenotypic response to the anti-cancer agent 3-bromopyruvate.

Lis P, Jurkiewicz P, Cal-Bąkowska M, Ko YH, Pedersen PL, Goffeau A, Ułaszewski S.

Oncotarget. 2016 Mar 1;7(9):10153-73. doi: 10.18632/oncotarget.7174.

4.

Transport of 3-bromopyruvate across the human erythrocyte membrane.

Sadowska-Bartosz I, Soszyński M, Ułaszewski S, Ko Y, Bartosz G.

Cell Mol Biol Lett. 2014 Jun;19(2):201-14. doi: 10.2478/s11658-014-0189-1. Epub 2014 Apr 9.

PMID:
24715475
5.

Killing multiple myeloma cells with the small molecule 3-bromopyruvate: implications for therapy.

Majkowska-Skrobek G, Augustyniak D, Lis P, Bartkowiak A, Gonchar M, Ko YH, Pedersen PL, Goffeau A, Ułaszewski S.

Anticancer Drugs. 2014 Jul;25(6):673-82. doi: 10.1097/CAD.0000000000000094.

PMID:
24557015
6.

3-Bromopyruvate: a novel antifungal agent against the human pathogen Cryptococcus neoformans.

Dyląg M, Lis P, Niedźwiecka K, Ko YH, Pedersen PL, Goffeau A, Ułaszewski S.

Biochem Biophys Res Commun. 2013 May 3;434(2):322-7. doi: 10.1016/j.bbrc.2013.02.125. Epub 2013 Mar 26.

PMID:
23541578
7.

Butyltin(IV) 2-sulfobenzoates: synthesis, structural characterization and their cytostatic and antibacterial activities.

Pruchnik H, Lis T, Latocha M, Zielińska A, Ułaszewski S, Pelińska I, Pruchnik FP.

J Inorg Biochem. 2012 Jun;111:25-32. doi: 10.1016/j.jinorgbio.2012.02.024. Epub 2012 Mar 5.

PMID:
22484249
8.

Transport and cytotoxicity of the anticancer drug 3-bromopyruvate in the yeast Saccharomyces cerevisiae.

Lis P, Zarzycki M, Ko YH, Casal M, Pedersen PL, Goffeau A, Ułaszewski S.

J Bioenerg Biomembr. 2012 Feb;44(1):155-61. doi: 10.1007/s10863-012-9421-8. Epub 2012 Feb 23.

PMID:
22359102
9.

The mammalian ABC transporter ABCA1 induces lipid-dependent drug sensitivity in yeast.

Bocer T, Zarubica A, Roussel A, Flis K, Trombik T, Goffeau A, Ulaszewski S, Chimini G.

Biochim Biophys Acta. 2012 Mar;1821(3):373-80. doi: 10.1016/j.bbalip.2011.07.005. Epub 2011 Jul 20.

PMID:
21787882
10.

Atg35, a micropexophagy-specific protein that regulates micropexophagic apparatus formation in Pichia pastoris.

Nazarko VY, Nazarko TY, Farré JC, Stasyk OV, Warnecke D, Ulaszewski S, Cregg JM, Sibirny AA, Subramani S.

Autophagy. 2011 Apr;7(4):375-85. Epub 2011 Apr 1.

11.

Vmr 1p is a novel vacuolar multidrug resistance ABC transporter in Saccharomyces cerevisiae.

Wawrzycka D, Sobczak I, Bartosz G, Bocer T, Ułaszewski S, Goffeau A.

FEMS Yeast Res. 2010 Nov;10(7):828-38. doi: 10.1111/j.1567-1364.2010.00673.x. Epub 2010 Sep 15.

12.

The physiological and morphological phenotype of a yeast mutant resistant to the quaternary ammonium salt N-(dodecyloxycarboxymethyl)-N,N,N-trimethyl ammonium chloride.

Obłak E, Gamian A, Adamski R, Ułaszewski S.

Cell Mol Biol Lett. 2010 Jun;15(2):215-33. doi: 10.2478/s11658-010-0002-8. Epub 2010 Jan 29.

PMID:
20140761
13.

Antifungal activity of organotin compounds with functionalized carboxylates evaluated by the microdilution bioassay in vitro.

Dylag M, Pruchnik H, Pruchnik F, Majkowska-Skrobek G, Ułaszewski S.

Med Mycol. 2010 Mar;48(2):373-83. doi: 10.1080/13693780903188680.

PMID:
19688632
14.

Synthesis, structure and antitumor activity of [RhCl3(N-N)(DMSO)] polypyridyl complexes.

Sliwińska U, Pruchnik FP, Pelińska I, Ułaszewski S, Wilczok A, Zajdel A.

J Inorg Biochem. 2008 Oct;102(10):1947-51. doi: 10.1016/j.jinorgbio.2008.07.004. Epub 2008 Jul 26.

PMID:
18718669
15.

The YJL185C, YLR376C and YJR129C genes of Saccharomyces cerevisiae are probably involved in regulation of the glyoxylate cycle.

Boniewska-Bernacka E, Wysocki R, Grochowalska R, Machnicka B, Ułaszewski S, Lachowicz T.

Acta Biochim Pol. 2006;53(4):739-45. Epub 2006 Dec 4.

16.
17.

Intragenic suppressors that restore the activity of the maturase encoded by the second intron of the Saccharomyces cerevisiae cyt b gene.

Maciaszczyk E, Ulaszewski S, Lazowska J.

Curr Genet. 2004 Aug;46(2):67-71. Epub 2004 May 27.

PMID:
15168075
18.

Transcriptional activation of metalloid tolerance genes in Saccharomyces cerevisiae requires the AP-1-like proteins Yap1p and Yap8p.

Wysocki R, Fortier PK, Maciaszczyk E, Thorsen M, Leduc A, Odhagen A, Owsianik G, Ulaszewski S, Ramotar D, Tamás MJ.

Mol Biol Cell. 2004 May;15(5):2049-60. Epub 2004 Feb 20.

19.

Different sensitivities of mutants and chimeric forms of human muscle and liver fructose-1,6-bisphosphatases towards AMP.

Rakus D, Tillmann H, Wysocki R, Ulaszewski S, Eschrich K, Dzugaj A.

Biol Chem. 2003 Jan;384(1):51-8.

PMID:
12674499

Supplemental Content

Loading ...
Support Center